The document discusses the treatment of cervical cancer. It recommends that concurrent chemoradiation with cisplatin is the standard treatment for locally advanced cervical cancer based on evidence from randomized trials showing improved survival. Neoadjuvant chemotherapy followed by surgery may be an alternative approach currently being tested in clinical trials. Bevacizumab is being studied as a potential targeted therapy in advanced or recurrent cervical cancer.